June 06, 2022
1 minute watch
Source/Disclosures
sources:
Nath A, et al. Neuropsychiatric and neurological complications of COVID-19. Presented at: American Psychiatric Association annual meeting; May 21-25, 2022; New Orleans.
Disclosures:
Nath reports no relevant financial disclosures.
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on . ” data-action=”subscribe”> Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Back to Healio
NEW ORLEANS – Autopsy results in otherwise healthy people who died from COVID-19 suggest that immunoglobulin therapy may be an effective treatment choice, Avindra Nath, MD, said at the American Psychiatric Association annual meeting.
Findings from autopsies in these patients “suggest extensive glial cell activation, including infiltration of macrophages, that is probably the prime mediator of many of the [psychiatric symptoms],” Nath said.
A new NIH trial will evaluate the effect of high-dose corticosteroids and IV immunoglobulin on immune parameters, he said
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on . ” data-action=”subscribe”> Subscribe
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Back to Healio
